Back
Open Access

Trends in angiotensin receptor/neprilysin inhibitor (ARNI) prescribing across multi-Centre, multi-ethnic heart failure population

Session: ePosters in chronic heart failure - pharmacotherapy (1)
Topic: Pharmacotherapy
Speaker: Ms C. Chua (Kuching, MY)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Ms Chelfi Zhi Fei Chua

Sarawak Heart Center, Kuching (Malaysia)
0 follower

5 more presentations in this session

Clinical and safety outcomes of a pharmacist-led medication therapy management clinic (MTM) for heart failure patients in a tertiary hospital in Singapore

Speaker: Doctor W. Lin (Singapore, SG)

Access
Abstract
Like
Thumbnail

Guideline-directed medical therapy optimization among multi-ethnic groups of heart failure with reduced ejection fraction patients

Speaker: Ms C. Chua (Kuching, MY)

Access
Abstract
Like
Thumbnail

Levosimendan in outpatients with Advanced heart failure and severe KidnEy disease: the out-LAKE registry

Speaker: Doctor G. Uccello (Lecco, IT)

Access
Abstract
Like
Thumbnail

Trend of echocardiographic parameters, ventricular-arterial coupling, and biomarkers in advanced heart failure patients undergoing intermittent home-based levosimendan infusion

Speaker: Doctor R. Pugliese (Brindisi, IT)

Access
Abstract
Like
Thumbnail

Intermittent levosimendan in advanced palliative heart failure improves quality of life and reduces heart failure decompensations: a single center-experience

Speaker: Doctor J. Quintal (Setubal, PT)

Access
Abstract
Like
Thumbnail

Access the full session

ePosters in chronic heart failure - pharmacotherapy (1)

Speakers: Ms C. Chua, Doctor W. Lin, Ms C. Chua, Doctor G. Uccello, Doctor R. Pugliese...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources